E-LIB Suche - Ergebnisse für: D'Alterio Crescenzo

1

Disulfide bond replacement with non-reducible side chain to..:

Trotta, Anna Maria ; Tomassi, Stefano ; Di Maiolo, Gaetana...
European Journal of Medicinal Chemistry. 276 (2024) - p. 116669 , 2024

Link: https://doi.org/10.1016/..

2

Targeting CXCR4 impaired T regulatory function through PTEN..:

Santagata, Sara ; Rea, Giuseppina ; Bello, Anna Maria...
British Journal of Cancer. 130 (2024) 12 - p. 2016-2026 , 2024

Link: https://doi.org/10.1038/..

3

CXCL12-loaded-hydrogel (CLG): a new device for metastatic C..:

Portella, Luigi ; Bertolini, Giulia ; Guardascione, Giuseppe...
Heliyon. , 2024

Link: https://doi.org/10.1016/..

4

HIGH EXPRESSION OF CXCR4 - CXCR7 - CXCL12 PREDICTS POOR SUR..:

Giardino, Alessandro ; Stefania, Scala ; D'Alterio, Crescenzo...
European Journal of Surgical Oncology. 49 (2023) 2 - p. e155 , 2023

Link: https://doi.org/10.1016/..

5

Hepatocellular carcinoma (HCC) tumor microenvironment is mo..:

Santagata, Sara ; Rea, Giuseppina ; Castaldo, Daniela...
Hepatology International. 18 (2023) 2 - p. 568-581 , 2023

Link: https://doi.org/10.1007/..

6

CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXC..:

D'Alterio, Crescenzo ; Giardino, Alessandro ; Scognamiglio, Giosuè...
Cells. 11 (2022) 21 - p. 3340 , 2022

Link: https://doi.org/10.3390/..

7

In PD-1+ human colon cancer cells NIVOLUMAB promotes surviv..:

Ieranò, Caterina ; Righelli, Dario ; D'Alterio, Crescenzo...
Journal for ImmunoTherapy of Cancer. 10 (2022) 3 - p. e004032 , 2022

Link: https://doi.org/10.1136/..

8

Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO..:

D'Alterio, Crescenzo ; Spina, Anna ; Arenare, Laura...
Cancers. 14 (2022) 7 - p. 1849 , 2022

Link: https://doi.org/10.3390/..

9

Novel Peptide-Based PET Probe for Non-invasive Imaging of C..:

Trotta, Anna Maria ; Aurilio, Michela ; D'Alterio, Crescenzo...
Journal of Medicinal Chemistry. 64 (2021) 6 - p. 3449-3461 , 2021

Link: https://doi.org/10.1021/..

10

Aflibercept or bevacizumab in combination with FOLFIRI as s..:

Ottaiano, Alessandro ; Scala, Stefania ; Santorsola, Mariachiara...
Therapeutic Advances in Medical Oncology. 13 (2021) - p. 175883592198922 , 2021

Link: https://doi.org/10.1177/..

11

A novel CXCR4 antagonist counteracts paradoxical generation..:

Bertolini, Giulia ; Cancila, Valeria ; Milione, Massimo...
Molecular Therapy. 29 (2021) 10 - p. 2963-2978 , 2021

Link: https://doi.org/10.1016/..

12

Unexpected tumor reduction in metastatic colorectal cancer ..:

Ottaiano, Alessandro ; Scala, Stefania ; D'Alterio, Crescenzo...
Therapeutic Advances in Medical Oncology. 13 (2021) - p. 175883592110114 , 2021

Link: https://doi.org/10.1177/..

13

New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Th..:

D'Alterio, Crescenzo ; Zannetti, Antonella ; Trotta, Anna Maria...
Cancers. 12 (2020) 7 - p. 1952 , 2020

Link: https://doi.org/10.3390/..

14

Paradoxical effects of chemotherapy on tumor relapse and me..:

D'Alterio, Crescenzo ; Scala, Stefania ; Sozzi, Gabriella..
Seminars in Cancer Biology. 60 (2020) - p. 351-361 , 2020

Link: https://doi.org/10.1016/..

15

New Insights on the Emerging Genomic Landscape of CXCR4 in ..:

Scala, Stefania ; D'Alterio, Crescenzo ; Milanesi, Samantha...
Vaccines. 8 (2020) 2 - p. 164 , 2020

Link: https://doi.org/10.3390/..